Intelomed To Present At New England Venture Summit

PITTSBURGH, PA--(Marketwired - December 02, 2015) -

Highlighted Links

InteloMed Website

1-800-PublicRelations, Inc.

InteloMed, Inc., an emerging leader and developer of software and informatics for non-invasive cardiovascular monitoring, will present at the 10th Annual New England Venture Summit on December 8 and 9. InteloMed President and CEO Jill Schiaparelli will lead the presentation at the Hilton Boston Dedham on December 9 at 11:40 am.

The New England Venture Summit aims to connect early stage, emerging growth, life sciences, medical device, and clean-tech innovators with investors and venture capitalists.

About InteloMed
InteloMed is redefining the standard of care in cardiovascular monitoring and informatics through its multi-dimensional, non-invasive CVInsight™ platform. The CVInsight™ platform provides real-time insights to inform clinical decisions in a variety of healthcare applications, including hospital and out-patient facilities, clinics, medical facilities and sleep labs. InteloMed is headquartered in Wexford, PA. For more information, visit www.InteloMed.com.

About The New England Venture Summit
The annual New England Venture Summit, presented by youngStartup Ventures, is the premier industry gathering connecting venture capitalists, corporate VCs, angel investors, technology transfer professionals, senior executives of early stage and emerging growth companies, university researchers, incubators and premier service providers. For more information, visit www.youngstartup.com/newengland2015.

Safe Harbor Statement
Certain statements in this release are "forward-looking" and as such are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the need to obtain additional capital in order to grow our business, our ability to engage qualified employees, the acceptance of new products by doctors and hospitals, changes in the regulatory environment and healthcare legislation, the need to keep pace with technological changes, our dependence on third party manufacturers to produce components of our technology platform on time and to our specifications, and the successful implementation of our commercial strategies.